GridAI Technologies (GRDX) Convertible Debt (2015 - 2020)
GridAI Technologies' (GRDX) quarterly Convertible Debt came in at $5.3 million in Q2 2020, up 187.69% YoY from $1.8 million in Q3 2019, and up 76.98% on a QoQ basis from $3.0 million in Q1 2020.
GridAI Technologies (GRDX) Convertible Debt (2015 - 2020) Analysis & Trends
GridAI Technologies (GRDX) has 6 years of Convertible Debt data on file, last reported at $5.3 million in Q2 2020.
- Quarterly Convertible Debt rose 187.69% year-over-year to $5.3 million in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $5.3 million (up 187.69% YoY) and the FY2019 annual result came in at $1.1 million, changed N/A from the prior year.
- Convertible Debt advanced to $5.3 million in Q2 2020, from $3.0 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $9.3 million in Q3 2016 to a low of $235487.0 in Q1 2018.
- A 5-year average of $2.2 million and a median of $1.4 million in 2019 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2017 — Convertible Debt plunged 95.92% — and 2019, when it jumped 633.99%.
- Tracing GRDX's Convertible Debt over 5 years: stood at $9.3 million in 2016, then slumped by 96.21% to $352713.0 in 2017, then decreased by 20.33% to $281024.0 in 2018, then surged by 283.22% to $1.1 million in 2019, then soared by 390.77% to $5.3 million in 2020.
- The last three Convertible Debt figures came in at $5.3 million (Q2 2020), $3.0 million (Q1 2020), and $1.1 million (Q4 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | GridAI Technologies | 5.95 Mn | 5.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 5.29 Mn |
| Mar 31, 2020 | 2.99 Mn |
| Dec 31, 2019 | 1.08 Mn |
| Sep 30, 2019 | 1.95 Mn |
| Jun 30, 2019 | 1.84 Mn |
| Mar 31, 2019 | 1.73 Mn |
| Jun 30, 2018 | 281,024.00 |
| Mar 31, 2018 | 235,487.00 |
| Dec 31, 2017 | 352,713.00 |
| Sep 30, 2017 | 379,432.00 |
| Jun 30, 2017 | 645,119.00 |
| Sep 30, 2016 | 9.30 Mn |
| Dec 31, 2015 | 6.15 Mn |